Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bifeprunox
2. Bifeprunox Mesilate
3. Du-127090
4. Du127090
1. 350992-13-1
2. Bifeprunox Mesilate
3. Du-127090
4. Du127090
5. Bifeprunox Mesylate [usan]
6. Bifeprunox (mesylate)
7. 350992-13-1 (mesylate)
8. Bifeprunox Methanesulfonate
9. 7-(4-(biphenyl-3-ylmethyl)piperazin-1-yl)benzoxazol-2(3h)-one Methanesulfonate
10. 8f018d8l02
11. Bifeprunox Mesylate (usan)
12. 2(3h)-benzoxazolone, 7-(4-((1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-, Monomethanesulfonate
13. Du 127090
14. Unii-8f018d8l02
15. Methanesulfonic Acid;7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3h-1,3-benzoxazol-2-one
16. Schembl1248663
17. Chembl2107317
18. Dtxsid00956533
19. Bcp02133
20. Bifeprunox Mesylate [who-dd]
21. Akos030254375
22. Bifeprunox Mesylate, >=98% (hplc)
23. 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone Monomethanesulfonate
24. Bifeprunox Methanesulfonate [mi]
25. Ft-0663112
26. A14091
27. D06567
28. E98792
29. A929992
30. J-019873
31. Q27270277
32. 7-(4-(biphenyl-3-ylmethyl)piperazin-1-yl)benzoxazol-2(3h)-one Methanesulphonate
33. 2(3h)-benzoxazolone, 7-(4-((1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-, Monomethanesulphonate
34. Methanesulfonic Acid--7-{4-[([1,1'-biphenyl]-3-yl)methyl]piperazin-1-yl}-1,3-benzoxazol-2-ol (1/1)
| Molecular Weight | 481.6 g/mol |
|---|---|
| Molecular Formula | C25H27N3O5S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 481.16714214 g/mol |
| Monoisotopic Mass | 481.16714214 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 649 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Bifeprunox manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bifeprunox, including repackagers and relabelers. The FDA regulates Bifeprunox manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bifeprunox API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bifeprunox supplier is an individual or a company that provides Bifeprunox active pharmaceutical ingredient (API) or Bifeprunox finished formulations upon request. The Bifeprunox suppliers may include Bifeprunox API manufacturers, exporters, distributors and traders.
click here to find a list of Bifeprunox suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bifeprunox DMF (Drug Master File) is a document detailing the whole manufacturing process of Bifeprunox active pharmaceutical ingredient (API) in detail. Different forms of Bifeprunox DMFs exist exist since differing nations have different regulations, such as Bifeprunox USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bifeprunox DMF submitted to regulatory agencies in the US is known as a USDMF. Bifeprunox USDMF includes data on Bifeprunox's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bifeprunox USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bifeprunox suppliers with USDMF on PharmaCompass.
Bifeprunox Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bifeprunox GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bifeprunox GMP manufacturer or Bifeprunox GMP API supplier for your needs.
A Bifeprunox CoA (Certificate of Analysis) is a formal document that attests to Bifeprunox's compliance with Bifeprunox specifications and serves as a tool for batch-level quality control.
Bifeprunox CoA mostly includes findings from lab analyses of a specific batch. For each Bifeprunox CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bifeprunox may be tested according to a variety of international standards, such as European Pharmacopoeia (Bifeprunox EP), Bifeprunox JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bifeprunox USP).
LOOKING FOR A SUPPLIER?
